Your browser doesn't support javascript.
Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020.
Alizon, Samuel; Selinger, Christian; Sofonea, Mircea T; Haim-Boukobza, Stéphanie; Giannoli, Jean-Marc; Ninove, Laetitia; Pillet, Sylvie; Thibault, Vincent; de Rougemont, Alexis; Tumiotto, Camille; Solis, Morgane; Stephan, Robin; Bressollette-Bodin, Céline; Salmona, Maud; L'Honneur, Anne-Sophie; Behillil, Sylvie; Lefeuvre, Caroline; Dina, Julia; Hantz, Sébastien; Hartard, Cédric; Veyer, David; Delagrèverie, Héloïse M; Fourati, Slim; Visseaux, Benoît; Henquell, Cécile; Lina, Bruno; Foulongne, Vincent; Burrel, Sonia.
  • Alizon S; MIVEGEC, CNRS, IRD, Université de Montpellier, France.
  • Selinger C; Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, Université PSL, Paris, France.
  • Sofonea MT; MIVEGEC, CNRS, IRD, Université de Montpellier, France.
  • Haim-Boukobza S; MIVEGEC, CNRS, IRD, Université de Montpellier, France.
  • Giannoli JM; Laboratoire CERBA, Saint-Ouen-L'Aumône, France.
  • Ninove L; BIOGROUP, Scientific Direction, Lyon, France.
  • Pillet S; Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207-IHU Méditerranée Infection), Marseille, France.
  • Thibault V; Laboratoire des agents infectieux et d'hygiène, CHU de Saint-Etienne, France.
  • de Rougemont A; CIRI, Centre International de Recherche en Infectiologie, GIMAP team, University of Lyon, University of Saint-Etienne, INSERM, U1111, CNRS UMR5308, ENS de Lyon, UCBL, Lyon, France.
  • Tumiotto C; Laboratoire de Virologie, CHU Rennes, Rennes, France.
  • Solis M; UMR PAM A 02.102 Procédés Alimentaires et Microbiologiques, Université de Bourgogne Franche-Comté/AgroSup Dijon, Dijon, France.
  • Stephan R; Laboratory of Virology-Serology, University Hospital of Dijon Bourgogne, Dijon, France.
  • Bressollette-Bodin C; University of Bordeaux, CNRS-UMR 5234, CHU Bordeaux, Virology Department, Bordeaux, France.
  • Salmona M; CHU de Strasbourg, Laboratoire de Virologie, Strasbourg, France, Université de Strasbourg, INSERM, IRM UMR_S 1109, Strasbourg, France.
  • L'Honneur AS; Laboratoire de Microbiologie, CHU Nîmes, Nîmes, France.
  • Behillil S; CHU Nantes, Nantes Université, Service de Virologie, Nantes, France.
  • Lefeuvre C; Laboratoire de Virologie, Hôpital Saint Louis, APHP, INSERM U976, équipe INSIGHT, Université de Paris, Paris, France.
  • Dina J; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Virologie, Paris, France.
  • Hantz S; National Reference Center for Respiratory Viruses, Molecular Genetics of RNA Viruses, UMR 3569 CNRS, University of Paris, Institut Pasteur, Paris, France.
  • Hartard C; Département de Biologie des Agents Infectieux, Laboratoire de Virologie, CHU d'Angers, Angers, France.
  • Veyer D; Laboratoire HIFIH, UPRES EA 3859, Université d'Angers, Angers, France.
  • Delagrèverie HM; Laboratoire de Virologie, CHU de Caen, UNICAEN, INSERM U1311 DYNAMICURE, Université de Caen Normandie, Caen, France.
  • Fourati S; CHU Limoges, Laboratoire de Bactériologie-Virologie-Hygiène, Limoges, France.
  • Visseaux B; RESINFIT, U 1092, University of Limoges, Limoges, France.
  • Henquell C; Laboratoire de Virologie, CHRU de Nancy Brabois, Vandoeuvre-lès-Nancy, France; Université de Lorraine, CNRS, LCPME, Nancy, France.
  • Lina B; Laboratoire de Virologie, Service de Microbiologie, hôpital européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris et Unité de Génomique Fonctionnelle des Tumeurs Solides, Centre de Recherche des Cordeliers, INSERM, Université Paris, Paris, France.
  • Foulongne V; AP-HP, Hôpital Avicenne, Laboratoire de microbiologie clinique, Bobigny, France.
  • Burrel S; Henri Mondor Hospital, virology department, Créteil, France.
Euro Surveill ; 27(6)2022 Feb.
Article in English | MEDLINE | ID: covidwho-1686391
ABSTRACT
BackgroundThe COVID-19 pandemic has led to an unprecedented daily use of RT-PCR tests. These tests are interpreted qualitatively for diagnosis, and the relevance of the test result intensity, i.e. the number of quantification cycles (Cq), is debated because of strong potential biases.AimWe explored the possibility to use Cq values from SARS-CoV-2 screening tests to better understand the spread of an epidemic and to better understand the biology of the infection.MethodsWe used linear regression models to analyse a large database of 793,479 Cq values from tests performed on more than 2 million samples between 21 January and 30 November 2020, i.e. the first two pandemic waves. We performed time series analysis using autoregressive integrated moving average (ARIMA) models to estimate whether Cq data information improves short-term predictions of epidemiological dynamics.ResultsAlthough we found that the Cq values varied depending on the testing laboratory or the assay used, we detected strong significant trends associated with patient age, number of days after symptoms onset or the state of the epidemic (the temporal reproduction number) at the time of the test. Furthermore, knowing the quartiles of the Cq distribution greatly reduced the error in predicting the temporal reproduction number of the COVID-19 epidemic.ConclusionOur results suggest that Cq values of screening tests performed in the general population generate testable hypotheses and help improve short-term predictions for epidemic surveillance.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Qualitative research Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 1560-7917.ES.2022.27.6.2100406

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Qualitative research Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 1560-7917.ES.2022.27.6.2100406